By Court Wing Leading psychedelic researcher, Robin Carhart-Harris, speaks with a participant in a psilocybin for depression trial on the potential of psychedelics. After our Op-Ed, “Re-evaluating the Results of the Recent Trial of Psilocybin vs Escitalopram for Depression”, came out, the author, Court Wing, followed up with Dr. Carhart-Harris to discuss the results and …

The post Psilocybin for Depression: A Q&A between Robin Carhart-Harris & a Psilocybin Study Participant appeared first on Psychedelics Today.

Previous articleMydecine Unveils Artificial Intelligence Drug Discovery Program
Next articleMINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression